Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
EurekAlert, 09/18/09
In early 2008, there was a frightening failure in drug safety processes. In just a few weeks, more than 100 Americans had died after being administered contaminated doses of the common blood thinner heparin. The contaminant, present in heparin manufactured in China and discovered with the help of scientists from Rensselaer Polytechnic Institute, was so structurally similar to pure heparin that is was undetectable to all but the most sophisticated detection techniques. As a result, many people became seriously ill or died around the world and the several hundred thousand patients that receive the drug every day in the U.S. were put at risk.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Pandemic toolkit offers flu with a view
EurekAlert, 12/15/09
Intensive therapy for narrowed arteries linked to fewer heart events
ScienceDaily, 12/15/09
New research identifies modifiable risk factors for heart disease
EurekAlert, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


